|
An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis |
Soares MO, Welton NJ, Harrison DA, Peura P, Hari MS, Harvey SE, Madan JJ, Ades AE, Palmer SJ, Royan KM |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Soares MO, Welton NJ, Harrison DA, Peura P, Hari MS, Harvey SE, Madan JJ, Ades AE, Palmer SJ, Royan KM. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis . Health Technology Assessment 2012; 16(7): 1-186 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Chemotherapy, Adjuvant /economics /standards; Cost-Benefit Analysis; Decision Support Techniques; Female; Great Britain; Humans; Immunoglobulins, Intravenous /administration & Male; Middle Aged; Multicenter Studies as Topic; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Sepsis /drug therapy /economics /mortality; State Medicine /economics /standards; Survival Analysis; dosage /economics /therapeutic use AccessionNumber 22012008908 Date bibliographic record published 26/04/2012 |
|
|
|